StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 11/3051% above fair value
$72.63−0.16 (-0.22%)

Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%

Bio-Techne pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bio-Techne's pe ratio was 62.8× on Nov 11, 2026, against 131.7× a year earlier. Over the last 5 years it ranged from 31.0× to 136.0×, with a median of 62.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202662.8×−57.3
2025Dec 31, 2025120.0×+43.4
2024Dec 31, 202476.6×+25.9
2023Dec 29, 202350.8×+4.5
2022Dec 30, 202246.3×−73.4
2021Dec 31, 2021119.8×+68.9
2020Dec 31, 202050.8×−41.0
2019Dec 31, 201991.8×+48.4
2018Dec 31, 201843.5×−23.0
2017Dec 29, 201766.4×+28.2
2016Dec 30, 201638.2×+6.9
2015Dec 31, 201531.4×−0.6
2014Dec 31, 201432.0×+1.3
2013Dec 31, 201330.6×+7.7
2012Dec 31, 201222.9×+0.6
2011Dec 30, 201122.4×−0.1
2010Dec 31, 201022.5×−2.2
2009Dec 31, 200924.7×–

More Bio-Techne figures

See a number that looks wrong?